لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Pilié PG; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Giuliani V; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., McGrail DJ; Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, Ohio., Bristow CA; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Ngoi NYL; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kyewalabye K; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wani KM; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Le H; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Campbell E; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sanchez NS; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yang D; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gheeya JS; The University of Texas Health Science Center at Houston, Houston, Texas., Goswamy RV; The University of Texas Health Science Center at Houston, Houston, Texas., Holla V; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shaw KR; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Liu CY; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Ma X; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Feng N; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Machado AA; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Bardenhagen JP; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vellano CP; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Marszalek JR; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Rajendra E; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Piscitello D; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Johnson TI; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Likhatcheva M; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Elinati E; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Majithiya J; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Neves J; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Grinkevich V; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Ranzani M; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Luzarraga MR; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Boursier M; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Armstrong L; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Geo L; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Lillo G; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Tse WY; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kopetz SE; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Geck Do MK; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lively S; ChemPartner Corporation, San Francisco, California., Johnson MG; ChemPartner Corporation, San Francisco, California., Robinson HMR; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Smith GCM; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Carroll CL; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Di Francesco ME; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jones P; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Heffernan TP; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Yap TA; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2121-2139.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Ataxia Telangiectasia Mutated Proteins*/genetics , Ataxia Telangiectasia Mutated Proteins*/antagonists & inhibitors , Neoplasms*/genetics , Neoplasms*/drug therapy , Neoplasms*/pathology, Animals ; Humans ; Mice ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/pharmacology ; Biomarkers, Tumor/genetics ; Cell Line, Tumor ; Loss of Function Mutation ; Xenograft Model Antitumor Assays

المؤلفون: Shaw KR; Hawai'i Pacific University Center for Marine Debris Research, Waimānalo, HI 96795, USA; National Institute of Standards and Technology, Waimānalo, HI 96795, USA. Electronic address: katherine.shaw@nist.gov., Whitney JL; NOAA Pacific Islands Fisheries Science Center, Honolulu, HI 96818, USA., Nalley EM; Sea Grant College Program, University of Hawai'i at Mānoa, Honolulu, HI 96815, USA; Hawai'i Institute of Marine Biology, University of Hawai'i at Mānoa, Kāne'ohe, HI 96744, USA., Schmidbauer MC; Hawai'i Institute of Marine Biology, University of Hawai'i at Mānoa, Kāne'ohe, HI 96744, USA., Donahue MJ; Hawai'i Institute of Marine Biology, University of Hawai'i at Mānoa, Kāne'ohe, HI 96744, USA., Black J; Hawai'i Pacific University Center for Marine Debris Research, Waimānalo, HI 96795, USA., Corniuk RN; Hawai'i Pacific University Center for Marine Debris Research, Waimānalo, HI 96795, USA., Teague K; Hawai'i Pacific University Center for Marine Debris Research, Waimānalo, HI 96795, USA., Sandquist R; Hawai'i Pacific University Center for Marine Debris Research, Waimānalo, HI 96795, USA., Pirkle C; Office of Public Health Studies, University of Hawai'i at Mānoa, Honolulu, HI 96822, USA., Dacks R; Sea Grant College Program, University of Hawai'i at Mānoa, Honolulu, HI 96815, USA., Sudnovsky M; Hawai'i Institute of Marine Biology, University of Hawai'i at Mānoa, Kāne'ohe, HI 96744, USA; NOAA, USA., Lynch JM; Hawai'i Pacific University Center for Marine Debris Research, Waimānalo, HI 96795, USA; National Institute of Standards and Technology, Waimānalo, HI 96795, USA.

المصدر: Marine pollution bulletin [Mar Pollut Bull] 2024 Jan; Vol. 198, pp. 115820. Date of Electronic Publication: 2023 Nov 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 0260231 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3363 (Electronic) Linking ISSN: 0025326X NLM ISO Abbreviation: Mar Pollut Bull Subsets: MEDLINE

مواضيع طبية MeSH: Microplastics* , Water Pollutants, Chemical*/analysis, Animals ; Humans ; Plastics/chemistry ; Environmental Monitoring/methods ; Fishes ; Micronesia

المؤلفون: Denu RA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yang RK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel SS; Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lewis VO; Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Livingston JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shaw KR; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ratan R; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zarzour MA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bird J; Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Raza S; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Akdemir KC; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rodon Ahnert J; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel S; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Dec 01; Vol. 29 (23), pp. 4844-4852.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Chondrosarcoma*/genetics , Chondrosarcoma*/pathology , Bone Neoplasms*/genetics , Bone Neoplasms*/pathology, Adult ; Humans ; Mutation ; Bone and Bones/pathology ; Genomics ; Isocitrate Dehydrogenase/genetics ; Isocitrate Dehydrogenase/metabolism ; Tumor Suppressor Protein p53/genetics

المؤلفون: Corniuk RN; Hawai'i Pacific University Center for Marine Debris Research, United States of America. Electronic address: rcorniuk@hpu.edu., Shaw KR; Hawai'i Pacific University Center for Marine Debris Research, United States of America; National Institute of Standards and Technology, United States of America., McWhirter A; Hawai'i Pacific University Center for Marine Debris Research, United States of America., Lynch HW 4th; Makanakai Marine Services, United States of America., Royer SJ; Hawai'i Pacific University Center for Marine Debris Research, United States of America., Lynch JM; Hawai'i Pacific University Center for Marine Debris Research, United States of America; National Institute of Standards and Technology, United States of America.

المصدر: Marine pollution bulletin [Mar Pollut Bull] 2023 Nov; Vol. 196, pp. 115570. Date of Electronic Publication: 2023 Sep 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 0260231 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3363 (Electronic) Linking ISSN: 0025326X NLM ISO Abbreviation: Mar Pollut Bull Subsets: MEDLINE

مواضيع طبية MeSH: Hunting* , Fisheries*, Hawaii ; Pacific Ocean ; Polymers

المؤلفون: Gangar S; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada., Sivakumaran S; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada., Anderson AN; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada., Shaw KR; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada., Estrela LA; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada., Kwok H; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada.; Hennick Bridgepoint Hospital, Sinai Health, Toronto, ON, Canada., Davies RC; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada.; Hennick Bridgepoint Hospital, Sinai Health, Toronto, ON, Canada.; Unity Health Toronto, Toronto, ON, Canada., Tong A; Hennick Bridgepoint Hospital, Sinai Health, Toronto, ON, Canada., Salbach NM; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada.; KITE, Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada.

المصدر: Physiotherapy theory and practice [Physiother Theory Pract] 2023 Aug 03; Vol. 39 (8), pp. 1704-1715. Date of Electronic Publication: 2022 Mar 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9015520 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-5040 (Electronic) Linking ISSN: 09593985 NLM ISO Abbreviation: Physiother Theory Pract Subsets: MEDLINE

مواضيع طبية MeSH: Stroke Rehabilitation* , Stroke*/diagnosis, Humans ; Inpatients ; Longitudinal Studies ; Secondary Data Analysis ; Postural Balance

المؤلفون: Shaw KR; School of Special Education, School Psychology, and Early Childhood Studies, College of Education, Anita Zucker Center for Excellence in Early Childhood Studies, University of Florida, Gainesville, FL, United States., Salloum RG; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States., Snyder PA; School of Special Education, School Psychology, and Early Childhood Studies, College of Education, Anita Zucker Center for Excellence in Early Childhood Studies, University of Florida, Gainesville, FL, United States.

المصدر: Frontiers in public health [Front Public Health] 2023 Jul 07; Vol. 11, pp. 1198206. Date of Electronic Publication: 2023 Jul 07 (Print Publication: 2023).

نوع المنشور: Review; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE

مواضيع طبية MeSH: Early Intervention, Educational* , Communication*, Humans ; Child ; Child, Preschool

المؤلفون: Shaw KR; Department of Environmental Toxicology, Texas Tech University, Lubbock, Texas, USA., Balazs GH; Golden Honu Services of Oceania, Honolulu, Hawaii, USA., Jones TT; Pacific Islands Fisheries Science Center, National Oceanic and Atmospheric Administration, Honolulu, Hawaii, USA., Lynch HW; Makanakai Marine Services, Honolulu, Hawaii, USA., Liu J; Environment Research Institute, Shandong University, Qingdao, China., Cobb GP; Department of Environmental Sciences, Baylor University, Waco, Texas, USA., Klein DM; Department of Civil Engineering, Texas Tech University, Lubbock, Texas, USA., Lynch JM; Chemical Sciences Division, National Institute of Standards and Technology, Waimānalo, Hawaii, USA.; Center for Marine Debris Research, Hawai'i Pacific University, Waimānalo, Hawaii, USA.

المصدر: Environmental toxicology and chemistry [Environ Toxicol Chem] 2023 May; Vol. 42 (5), pp. 1109-1123. Date of Electronic Publication: 2023 Apr 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: SETAC Press Country of Publication: United States NLM ID: 8308958 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-8618 (Electronic) Linking ISSN: 07307268 NLM ISO Abbreviation: Environ Toxicol Chem Subsets: MEDLINE

مواضيع طبية MeSH: Turtles* , Water Pollutants, Chemical*/analysis , Metals, Heavy*/analysis , Arsenic*/analysis, Animals ; Hawaii ; Lead/analysis

المؤلفون: Alhalabi O; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: oalhalabi@mdanderson.org., Zhu Y; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Biotherapy, Cancer Center and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China., Hamza A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Qiao W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin Y; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang RM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shah AY; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Campbell MT; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Holla V; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kamat A; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chen J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meng J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang M; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bondaruk J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Titus M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Genovese G; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Czerniak BA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shaw KR; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Guo CC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Logothetis CJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Siefker-Radtke A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Msaouel P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang L; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu J; Department of Biotherapy, Cancer Center and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China., Gao J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jgao1@mdanderson.org.

المصدر: European urology oncology [Eur Urol Oncol] 2023 Apr; Vol. 6 (2), pp. 228-232. Date of Electronic Publication: 2021 Nov 14.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Transitional Cell*/drug therapy, Humans ; Prognosis ; Genomics ; Cisplatin/therapeutic use ; Proportional Hazards Models

المؤلفون: Davis JS; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston.; Now with Department of Cancer Biology, University of Kansas Medical Center, Kansas City., Chavez JC; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Cancer Prevention Research Training Program, The University of Texas MD Anderson Cancer Center, Houston.; Now with Stanford University School of Medicine, Stanford, California., Kok M; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Cancer Prevention Research Training Program, The University of Texas MD Anderson Cancer Center, Houston.; Now with Baylor College of Medicine, Houston, Texas., San Miguel Y; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Cancer Prevention Research Training Program, The University of Texas MD Anderson Cancer Center, Houston.; Now with Abbott Laboratories, Chicago, Illinois., Lee HY; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Cancer Prevention Research Training Program, The University of Texas MD Anderson Cancer Center, Houston., Henderson H; Department of Cancer Prevention Research Training Program, The University of Texas MD Anderson Cancer Center, Houston.; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston.; Now with Foundation Medicine, Atlanta, Georgia., Overman MJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Morris V; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Kee B; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Fogelman D; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; Now with Merck & Co, Philadelphia, Pennsylvania., Advani SM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; Now with Terasaki Institute of Biomedical Innovation, Los Angeles, California., Johnson B; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Parseghian C; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Shen JP; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Dasari A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Shaw KR; Department of Sheikh Khalifa Nahyan Ben Zayed Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston., Vilar E; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston., Raghav KP; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Shureiqi I; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; Now with Department of Cancer Biology, University of Michigan Medical School, Ann Arbor., Wolff RA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston., Maru D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston., Menter DG; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Chang S; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Cancer Prevention Research Training Program, The University of Texas MD Anderson Cancer Center, Houston.

المصدر: JAMA network open [JAMA Netw Open] 2022 Oct 03; Vol. 5 (10), pp. e2236357. Date of Electronic Publication: 2022 Oct 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Aspirin*/therapeutic use , Colorectal Neoplasms*, Aged ; Body Mass Index ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Obesity/complications ; Obesity/drug therapy ; Obesity/epidemiology